Skip to content

About
Sign up
Contact

Visit

Home (current)
Diseases
CLL
Multiple Myeloma
Lymphoma
ALL
AML
Myelodysplastic Syndromes
View all Diseases
Topics
Transplantation
Measurable Residual Disease
CAR-T & Cellular Therapy
Pharmacy
Nursing
Supportive Care
View all Topics
Conferences
MDS
2020
2nd European
CAR T-Cell Meeting
ASH
2019
MPN Advances Day
2019
iwCAR-T
2019
COSTEM
2019
View all Conferences
Features
Podcasts

About
Sign up
Contact

subcutaneous rituximab

Subcutaneous rituximab versus intravenous rituximab – safety and efficacy results

VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Continue

Please enter your details if you would like to receive the latest hemonc news and updates

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Disease Channels

CLL
Multiple Myeloma
Lymphoma
ALL
AML
Myelodysplastic Syndromes
View all

Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals

Cookie Policy
Privacy Policy
Terms of Use
Editorial Policy